Search SAMHSA Publications and Digital Products
Store Facets Summary
- Clear all filters
- Remove People with Substance Use or Abuse Problems as Audience
- Remove Adolescents as Audience
- Remove Children as Audience
- Remove Non-Profits & Faith-Based Organizations
- Remove People with Substance Use or Abuse Problems as Population Group
- Remove Substance Abuse
- Remove 12 Step Programs
- Remove Education
- Remove Naltrexone
- Remove Cognitive Therapy
- Remove Outpatient Treatment
Main page content
Published: August 2021
The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Published: July 2021
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
Anger Management for Substance Abuse and Mental Health Clients: A Cognitive-Behavioral Therapy Manual
Published: October 2019
This updated manual contains a 12-week cognitive–behavioral anger management group treatment model. The content includes specific instructions and suggested remarks for group leaders, and exercises for group members. This model will work in a variety of clinical settings, and with diverse audiences.